Summary
Glucagon-like peptide-l(7–36)amide has been described as exerting potent glycogenic action and as stimulating glycolysis in skeletal muscle. We exposed isolated rat soleus muscle strips to various concentrations of glucagon-like peptide-l (7–36) amide (10-11-10-6 mol/l) or insulin (10-10-10-7 mol/l) and determined the respective effects on glucose metabolism. Insulin markedly increased the rate of glucose incorporation into glycogen with a maximal effect at 10-8 mol/l insulin (348±46% of intraindividual control experiment, p < 0.005), while glucagonlike peptide-1 (7–36)amide was without an effect (e.g. 10-11 mol/l, 96±10%; 10-9mol/l, 104±9%; 10-7 mol/l, 121±13 %; not significant). Likewise, glucagon-like peptide-1 (7–36) amide did not affect the rate of 3H-2-deoxy-glucose transport or glycogen content of soleus muscle strips. The rates of aerobic or anaerobic glycolysis were also not increased. The findings were independent of peptide source and of employed muscle size. Our results do not suggest any effect of glucagon-like peptide-1 (7–36)amide on skeletal muscle glucose metabolism and, hence, are in contrast to data derived from similar experiments by others.
Article PDF
Abbreviations
- GLP-l(7-36)amide:
-
glucagon-like peptide-1 (7–36)amide
- BSA:
-
bovine serum albumin'
- KRB:
-
Krebs-Ringer bicarbonate buffer (pH 7.4)
References
ørskov C (1992) Glucagon-like peptide-1, a new hormone of the enteroinsular axis. Diabetologia 35: 701–711
Gutniak M, Ørskov C, Holst JJ, Ahren B, Efendic S (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7–36) amide in normal subjects and patients with diabetes mellitus. New Engl J Med 326: 1316–1322
Thorens B (1992) Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide-1. Proc Natl Acad Sci USA 89: 8641–8645
Valverde I, Morales M, Clemente F et al. (1994) Glucagon-like peptide-1: a potent glycogenic hormone. FEBS letters 349: 313–316
Wheeler MB, Lu M, Dillon JS, Leng X-H, Chen C, Boyd AE (1993) Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 133: 57–62
Villanueva-Penacarrillo ML, Alcantara AI, Clemente F, Delgado E, Valverde I (1994) Potent glycogenic effect of GLP-l(7-36)amide in rat skeletal muscle. Diabetologia 37: 1163–1166
Crettaz M, Prentki M, Zanietti D, Jeanrenaud B (1980) Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites. Biochem J 186: 525–534
Challiss RAJ, Lozeman FJ, Leighton B, Newsholme EA (1986) Effects of the beta-adrenoreceptor agonist isoprenaline on insulin-sensitivity in soleus muscles of the rat. Biochem J 233: 377–381
Leighton B, Budohoski L, Lozeman FJ, Challiss RAJ, Newsholme EA (1985) The effects of prostaglandin El, E2, and F2alpha and indomethacin on the sensitivity of glycolysis and glycogen synthesis to insulin in stripped soleus muscle of the rat. Biochem J 227: 337–340
Bonen A, Clark MG, Henriksen EJ (1994) Experimental approaches in muscle metabolism hindlimb perfusion and isolated muscle incubations. Am J Physiol 266: E1-E16
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fürnsinn, C., Ebner, K. & Waldhäusl, W. Failure of GLP-l(7–36)amide to affect glycogenesis in rat skeletal muscle. Diabetologia 38, 864–867 (1995). https://doi.org/10.1007/s001250050365
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050365